Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 1, 2008
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three months ended March 31, 2008.Q1 2008 Summary --------------- - Initiated discussions with...
-
Apr 24, 2008
- First quarter financial results to be released on Thursday, May 1, 2008 Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, April 24 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host a...
-
Apr 1, 2008
Cipher Pharmaceuticals Inc. (TSX: DND) today announced it will hold its Annual Meeting of Shareholders on Thursday, April 10, 2008 at 4:30 p.m. ET.WHAT: ANNUAL MEETING OF SHAREHOLDERS WHERE:...
-
Feb 27, 2008
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the fourth quarter and fiscal year ended December 31, 2007. Fiscal 2007 Summary...
-
Feb 20, 2008
- Fourth quarter and year end financial results to be released on February 27, 2008 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Feb. 20 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND),...
-
Feb 11, 2008
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that the U.S. Food and Drug Administration (FDA) has suggested an additional statistical sensitivity analysis of existing clinical data on...
-
Feb 1, 2008
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it has received a written response from the U.S. Food and Drug Administration (FDA) regarding its appeal of the Agency's Approvable...
-
Jan 8, 2008
Cipher Pharmaceuticals Inc. (TSX: DND), an emerging specialty pharmaceutical company, today provided an update on recent developments with its products. CIP-ISOTRETINOIN In June 2007, Cipher...
-
Dec 5, 2007
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that Dr. Stefan Aigner, M.D., CFA, has been appointed to its Board of Directors. Dr. Aigner has more than 20 years of experience in the...
-
Dec 4, 2007
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it has appealed the position taken by the U.S. Food and Drug Administration (FDA) in its approvable letter for CIP-TRAMADOL ER, using...
-
Nov 7, 2007
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three and nine months ended September 30, 2007.Q3 2007 Summary --------------- - Entered into a...
-
Oct 22, 2007
- Third quarter financial results to be released on November 7, 2007 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Oct. 22 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host a...
-
Oct 16, 2007
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that Mr. William C. Garriock, B.Comm, MBA, has been appointed Chairman of Cipher Pharmaceuticals' Board of Directors replacing Dr. John Mull,...
-
Sep 10, 2007
Cipher Pharmaceuticals Inc. (TSX: DND) solemnly announces the passing of Mr. Waldemar Zimmerman, Vice-Chairman and Lead Director of Cipher's Board of Directors. "It is with profound sadness that...
-
Aug 13, 2007
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that the U.S. Food and Drug Administration (FDA) has responded to the Company's request for formal dispute resolution of the decision to...
-
Jul 24, 2007
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three and six months ended June 30, 2007.Q2 2007 Summary --------------- - CIP-FENOFIBRATE...
-
Jul 13, 2007
- Second quarter financial results to be released on July 24, 2007 -Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, July 13 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host a...
-
Jul 10, 2007
Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced that it has entered into a definitive licensing and distribution agreement with ProEthic Pharmaceuticals Inc...